• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于不良结局途径框架的 COVID-19 数据的系统组织。

Systematic Organization of COVID-19 Data Supported by the Adverse Outcome Pathway Framework.

机构信息

Institute of Environmental Medicine, Karolinska Institute, Stockholm, Sweden.

Environment Health and Safety Division, Environment Directorate, Organisation for Economic Cooperation and Development, Paris, France.

出版信息

Front Public Health. 2021 May 19;9:638605. doi: 10.3389/fpubh.2021.638605. eCollection 2021.

DOI:10.3389/fpubh.2021.638605
PMID:34095051
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8170012/
Abstract

Adverse Outcome Pathways (AOP) provide structured frameworks for the systematic organization of research data and knowledge. The AOP framework follows a set of key principles that allow for broad application across diverse disciplines related to human health, including toxicology, pharmacology, virology and medical research. The COVID-19 pandemic engages a great number of scientists world-wide and data is increasing with exponential speed. Diligent data management strategies are employed but approaches for systematically organizing the data-derived information and knowledge are lacking. We believe AOPs can play an important role in improving interpretation and efficient application of scientific understanding of COVID-19. Here, we outline a newly initiated effort, the CIAO project (https://www.ciao-covid.net/), to streamline collaboration between scientists across the world toward development of AOPs for COVID-19, and describe the overarching aims of the effort, as well as the expected outcomes and research support that they will provide.

摘要

不良结局途径(AOP)为系统组织研究数据和知识提供了结构化框架。AOP 框架遵循一系列关键原则,允许在与人类健康相关的多个学科中广泛应用,包括毒理学、药理学、病毒学和医学研究。COVID-19 大流行使全球许多科学家参与其中,数据呈指数级速度增长。人们采用了精心的数据管理策略,但缺乏系统组织数据衍生信息和知识的方法。我们相信,AOP 可以在提高对 COVID-19 的科学理解的解释和有效应用方面发挥重要作用。在这里,我们概述了一个新启动的项目,即 CIAO 项目(https://www.ciao-covid.net/),旨在促进全球科学家之间的合作,制定针对 COVID-19 的 AOP,并描述了该项目的总体目标,以及预期的结果和研究支持。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/66ce/8170012/41269a10400b/fpubh-09-638605-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/66ce/8170012/1e07bc439811/fpubh-09-638605-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/66ce/8170012/41269a10400b/fpubh-09-638605-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/66ce/8170012/1e07bc439811/fpubh-09-638605-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/66ce/8170012/41269a10400b/fpubh-09-638605-g0002.jpg

相似文献

1
Systematic Organization of COVID-19 Data Supported by the Adverse Outcome Pathway Framework.基于不良结局途径框架的 COVID-19 数据的系统组织。
Front Public Health. 2021 May 19;9:638605. doi: 10.3389/fpubh.2021.638605. eCollection 2021.
2
COVID-19 through Adverse Outcome Pathways: Building networks to better understand the disease - 3rd CIAO AOP Design Workshop.COVID-19 通过不良结局途径:构建网络以更好地了解疾病 - 第三届 CIAO AOP 设计研讨会。
ALTEX. 2022;39(2):322–335. doi: 10.14573/altex.2112161. Epub 2022 Jan 3.
3
CIAO: a living experiment in interdisciplinary large-scale collaboration facilitated by the Adverse Outcome Pathway framework.CIAO:通过不良反应途径框架促进的跨学科大规模合作的活体实验。
Front Public Health. 2023 Aug 10;11:1212544. doi: 10.3389/fpubh.2023.1212544. eCollection 2023.
4
Understanding COVID-19 through adverse outcome pathways - 2nd CIAO AOP Design Workshop.通过不良结局途径理解 COVID-19-第二届 CIAO AOP 设计研讨会。
ALTEX. 2021;38(2):351-357. doi: 10.14573/altex.2102221. Epub 2021 Mar 5.
5
The Adverse Outcome Pathway Framework Applied to Neurological Symptoms of COVID-19.应用于 COVID-19 神经系统症状的不良结局途径框架。
Cells. 2022 Oct 28;11(21):3411. doi: 10.3390/cells11213411.
6
Beyond chemicals: Opportunities and challenges of integrating non-chemical stressors in adverse outcome pathways.超越化学物质:整合非化学应激物于不良结局途径的机遇与挑战。
ALTEX. 2024;41(2):233-247. doi: 10.14573/altex.2307061. Epub 2023 Nov 17.
7
Adverse outcome pathway (AOP) development I: strategies and principles.不良结局途径(AOP)的发展I:策略与原则。
Toxicol Sci. 2014 Dec;142(2):312-20. doi: 10.1093/toxsci/kfu199.
8
Adverse outcome pathway: a path toward better data consolidation and global co-ordination of radiation research.不良结局途径:一种更好地整合数据和协调全球辐射研究的途径。
Int J Radiat Biol. 2022;98(12):1694-1703. doi: 10.1080/09553002.2021.2020363. Epub 2022 Jan 7.
9
Adverse outcome pathways and linkages to transcriptomic effects relevant to ionizing radiation injury.与电离辐射损伤相关的不良结局途径和转录组效应的联系。
Int J Radiat Biol. 2022;98(12):1789-1801. doi: 10.1080/09553002.2022.2110313. Epub 2022 Aug 22.
10
Development and application of the adverse outcome pathway framework for understanding and predicting chronic toxicity: I. Challenges and research needs in ecotoxicology.用于理解和预测慢性毒性的不良结局途径框架的开发与应用:I. 生态毒理学中的挑战与研究需求
Chemosphere. 2015 Feb;120:764-77. doi: 10.1016/j.chemosphere.2014.09.068. Epub 2014 Nov 11.

引用本文的文献

1
Building an Adverse Outcome Pathway network for COVID-19.构建2019冠状病毒病的不良结局途径网络。
Front Syst Biol. 2024 Jun 6;4:1384481. doi: 10.3389/fsysb.2024.1384481.
2
A systematic scoping review of the neurological effects of COVID-19.一项关于 COVID-19 对神经系统影响的系统范围综述。
Neurotoxicology. 2024 Jul;103:16-26. doi: 10.1016/j.neuro.2024.05.003. Epub 2024 May 18.
3
Expanding adverse outcome pathways towards one health models for nanosafety.拓展纳米安全性的不良结局途径,迈向“同一健康”模式

本文引用的文献

1
Artificial-intelligence tools aim to tame the coronavirus literature.人工智能工具旨在梳理新冠病毒相关文献。
Nature. 2020 Jun 9. doi: 10.1038/d41586-020-01733-7.
2
Susceptibility to misinformation about COVID-19 around the world.世界各地对新冠疫情错误信息的易感性。
R Soc Open Sci. 2020 Oct 14;7(10):201199. doi: 10.1098/rsos.201199. eCollection 2020 Oct.
3
Clinical presentation and outcomes of hospitalized adults with COVID-19: A systematic review.COVID-19 住院成年患者的临床表现和结局:一项系统综述。
Front Toxicol. 2023 Aug 25;5:1176745. doi: 10.3389/ftox.2023.1176745. eCollection 2023.
4
CIAO: a living experiment in interdisciplinary large-scale collaboration facilitated by the Adverse Outcome Pathway framework.CIAO:通过不良反应途径框架促进的跨学科大规模合作的活体实验。
Front Public Health. 2023 Aug 10;11:1212544. doi: 10.3389/fpubh.2023.1212544. eCollection 2023.
5
A curated gene and biological system annotation of adverse outcome pathways related to human health.精心策划的与人类健康相关的不良结局途径的基因和生物系统注释。
Sci Data. 2023 Jun 24;10(1):409. doi: 10.1038/s41597-023-02321-w.
6
Toxicogenomics Data for Chemical Safety Assessment and Development of New Approach Methodologies: An Adverse Outcome Pathway-Based Approach.毒理基因组学数据在化学品安全评估和新方法开发中的应用:基于不良结局路径的方法。
Adv Sci (Weinh). 2023 Jan;10(2):e2203984. doi: 10.1002/advs.202203984. Epub 2022 Dec 7.
7
The Adverse Outcome Pathway Framework Applied to Neurological Symptoms of COVID-19.应用于 COVID-19 神经系统症状的不良结局途径框架。
Cells. 2022 Oct 28;11(21):3411. doi: 10.3390/cells11213411.
8
Gut as an Alternative Entry Route for SARS-CoV-2: Current Evidence and Uncertainties of Productive Enteric Infection in COVID-19.肠道作为严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的另一条进入途径:2019冠状病毒病(COVID-19)中肠道感染的现有证据及不确定性
J Clin Med. 2022 Sep 26;11(19):5691. doi: 10.3390/jcm11195691.
9
Mechanistic Understanding of the Olfactory Neuroepithelium Involvement Leading to Short-Term Anosmia in COVID-19 Using the Adverse Outcome Pathway Framework.利用不良结局路径框架理解 COVID-19 导致短期嗅觉丧失的嗅神经上皮参与的机制。
Cells. 2022 Sep 27;11(19):3027. doi: 10.3390/cells11193027.
10
Mechanisms Leading to Gut Dysbiosis in COVID-19: Current Evidence and Uncertainties Based on Adverse Outcome Pathways.COVID-19导致肠道微生物群失调的机制:基于不良结局途径的当前证据与不确定性
J Clin Med. 2022 Sep 14;11(18):5400. doi: 10.3390/jcm11185400.
J Adv Nurs. 2020 Dec;76(12):3235-3257. doi: 10.1111/jan.14558. Epub 2020 Sep 30.
4
A putative AOP for pneumonia related to COVID-19.一种与2019冠状病毒病相关的肺炎假定不良结局途径。
Arch Toxicol. 2020 Sep;94(9):3343-3345. doi: 10.1007/s00204-020-02860-w. Epub 2020 Jul 20.
5
A mechanistic model and therapeutic interventions for COVID-19 involving a RAS-mediated bradykinin storm.涉及 RAS 介导的缓激肽风暴的 COVID-19 的机械模型和治疗干预。
Elife. 2020 Jul 7;9:e59177. doi: 10.7554/eLife.59177.
6
Considering how biological sex impacts immune responses and COVID-19 outcomes.考虑到生物性别如何影响免疫反应和 COVID-19 的结果。
Nat Rev Immunol. 2020 Jul;20(7):442-447. doi: 10.1038/s41577-020-0348-8. Epub 2020 Jun 11.
7
ACE2 expression and sex disparity in COVID-19.2019冠状病毒病中血管紧张素转换酶2的表达与性别差异
Cell Death Discov. 2020 May 26;6:37. doi: 10.1038/s41420-020-0276-1. eCollection 2020.
8
Adverse outcome pathways as a tool for the design of testing strategies to support the safety assessment of emerging advanced materials at the nanoscale.不良结局途径作为一种工具,用于设计测试策略,以支持纳米级新兴先进材料的安全性评估。
Part Fibre Toxicol. 2020 May 25;17(1):16. doi: 10.1186/s12989-020-00344-4.
9
Coronaviruses pathogenesis, comorbidities and multi-organ damage - A review.冠状病毒发病机制、合并症和多器官损伤 - 综述。
Life Sci. 2020 Aug 15;255:117839. doi: 10.1016/j.lfs.2020.117839. Epub 2020 May 22.
10
Harnessing the power of novel animal-free test methods for the development of COVID-19 drugs and vaccines.利用新型无动物测试方法的力量开发 COVID-19 药物和疫苗。
Arch Toxicol. 2020 Jun;94(6):2263-2272. doi: 10.1007/s00204-020-02787-2. Epub 2020 May 23.